Patents by Inventor Carsten H. Nielsen

Carsten H. Nielsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating cancer sensitive to anti-EGFR therapy and modifying treatment using peroxiredoxin 6 biomarker
    Patent number: 9588122
    Abstract: The present disclosure provides methods of treating cancer and modifying a cancer treatment for a cancer with an anti-EGFR drug by creating PRDX6 expression profiles and using the profiles to evaluate and optionally modify treatment. The present disclosure also provides assays and systems for assessing sensitivity of a cancer to an anti-EGFR therapy.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: March 7, 2017
    Assignee: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    Inventors: Edwin Chang, Lingyun Xu, Nick Hughes, Carsten H. Nielsen, Sanjiv S. Gambhir, Parag Mallick, Arutselvan Natarajan
  • METHODS OF TREATING CANCER SENSITIVE TO ANTI-EGFR THERAPY AND MODIFYING TREATMENT USING BLOOD BIOMARKERS
    Publication number: 20140275073
    Abstract: The present disclosure provides methods of treating cancer and modifying a cancer treatment for a cancer with an anti-EGFR drug by creating PRDX6 expression profiles and using the profiles to evaluate and optionally modify treatment. The present disclosure also provides assays and systems for assessing sensitivity of a cancer to an anti-EGFR therapy.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Inventors: Edwin Chang, Lingyun Xu, Nick Hughes, Carsten H. Nielsen, Sanjiv S. Gambhir, Parag Mallick, Arutselvan Natarajan